Clinical Trial

A Study of ARC-02 in B-cell NHL

Name: A Study of ARC-02 in B-cell NHL — clinical trial record (NCT07691606)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ABLATE-101

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is to assess safety, tolerability, pharmacokinetics (PK), pharmacodynamic (PD), and preliminary efficacy of ARC-02.

Trial Details

NCT Number	NCT07691606
Lead Sponsor	Taiho Oncology, Inc.
Conditions	B-cell Non Hodgkin Lymphoma
Enrollment	140 participants
Start Date	2026-06-22
Primary Completion	2029-01 (estimated)
Study Completion	2030-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-28